Developer docs
API playgroundTry for free, no card

Search company profiles

BPEA

Full company profile

uuid0000p96

Namestring
BPEA
Legal namestring
Brooke Private Equity Associates Management, LLC
Websiteurl
bpea-pe.com
Company typeenum
Private
Founded yearint
2002
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
private equity investing, lower middle market buyouts, growth equity investments, fund of funds management, healthcare private equity
NAICS code1 code
  • Portfolio Management and Investment Advice52394
SIC code1 code
  • Investment Advice6282
Product category
Private Equity (Asset Management)
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Fund Management Fees
TypeManaged Services
Description

BPEA generates revenue through management fees and carried interest from private equity funds including BPEA V ($218M) and BPEA Strategic Healthcare ($352M). The firm builds diversified and balanced private equity programs investing in fund managers and directly in companies.

bpea-pe.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

BPEA is a private equity firm that manages dedicated small and lower middle market buyout and growth equity investment programs for institutional investors. The firm builds diversified private equity portfolios by investing in fund managers and directly in US-based companies across business services & software, healthcare, consumer & retail, and industrial sectors, with a specialized healthcare-only program supported by Taft-Hartley investors.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • BPEA V closed at $218 million exceeding its $200 million target
+2 more records
Product overview1 text field

BPEA is a Boston-based private equity firm established in 2002 offering investment programs including Small Buyout and Growth (targeting companies with EBITDA below $10M and enterprise values below $100M), dedicated Healthcare funds (investing in healthcare services, healthcare IT, and consumer-oriented healthcare), and Customized separate accounts. The firm manages funds like BPEA V ($218M) and BPEA Strategic Healthcare ($352M). BPEA invests in both fund managers and directly in private companies across business services & software, healthcare, consumer & retail, and industrial sectors.

Product and service5 records
1BPEA V
CategoryPrivate Equity Fund
Description

Small buyout and growth equity fund investing in US-based companies with EBITDA below $10 million and enterprise values below $100 million across business services & software, healthcare, consumer & retail, and industrial sectors, both in funds and alongside funded and independent sponsors. Closed at $218M in December 2020.

2BPEA Strategic Healthcare Fund
CategoryPrivate Equity Fund (Healthcare Sector)
Description

Dedicated healthcare private equity fund investing in private healthcare companies directly and through specialist healthcare private equity firms. Targets companies addressing critical healthcare needs and improving access to cost-effective, high quality healthcare. Closed at $352M in 2020 from 16 Taft-Hartley Investors.

3Small Buyout and Growth Program
CategoryInvestment Program
Description

Investment program targeting profitable US businesses with enterprise values below $100 million and EBITDA between $1 million and $10 million, as well as sector-focused fund managers with fund sizes generally below $300 million. Builds diversified, balanced small-market PE portfolios.

4Healthcare Investment Program
CategoryInvestment Program (Healthcare Sector)
Description

Healthcare-focused investment program investing in fund managers and direct portfolio companies across healthcare services, healthcare IT, and consumer-oriented healthcare sectors. Leverages Taft-Hartley investor relationships for strategic value-add to portfolio companies serving those plans.

5Customized Investment Solutions
CategoryInvestment Solution / Separate Account
Description

Customized private equity programs developed for institutional investors, including global mandates, regionally-concentrated programs, and MWBE-focused investment strategies tailored to specific long-term goals.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Globally focused lower middle market private equity firm investing in companies with EBITDA typically under $25M. Highly comparable to BPEA's sub-$100M EV, sub-$10M EBITDA small buyout strategy across multiple sectors.

TypeDirect peer
Description

Middle market private equity firm focused on buyouts of North American companies. Comparable to BPEA as a lower middle market PE sponsor pursuing control investments with similar institutional LP base.

TypeDirect peer
Description

Lower middle market private equity firm investing in services, healthcare, and consumer companies. Directly comparable to BPEA in target company size and sector focus, including healthcare exposure.

TypeDirect peer
Description

Lower middle market PE firm focused on consumer, business services, and healthcare. Comparable to BPEA in fund size, target company profile, and multi-sector small buyout strategy.

TypeDirect peer
Description

Healthcare-focused private equity firm investing in lower middle market healthcare services and technology companies. Directly comparable to BPEA Strategic Healthcare's dedicated healthcare mandate.

TypeDirect peer
Description

Healthcare-focused private equity firm investing in middle market healthcare companies. Comparable to BPEA's dedicated healthcare fund strategy and target company size range.

TypeDirect peer
Description

Middle market private equity firm investing in North American companies across business services, healthcare, and consumer. Comparable to BPEA in lower middle market focus and sector breadth.

TypeBroad incumbent
Description

Global private equity firm co-founded by Peter Brooke, BPEA's late co-founder. Comparable as a multi-fund, multi-sector PE platform with shared founding lineage, though operating at substantially larger scale.

TypeBroad incumbent
Description

Global growth private equity firm also founded by Peter Brooke. Comparable as a multi-fund PE platform sharing founder pedigree, though focused on growth equity at larger company sizes than BPEA's small buyout strategy.

TypeOthers
Description

Private markets investment manager and fund-of-funds. Comparable to BPEA's fund-of-funds activity investing in other PE managers, though HarbourVest operates at significantly larger scale as a multi-strategy alternatives platform.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers89 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles19 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment23 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BPEA

Private Equity (Asset Management)bpea-pe.com

BPEA firmographics

Firmographics
Name
BPEA
Legal name
Brooke Private Equity Associates Management, LLC
Website
https://bpea-pe.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Where BPEA is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices1 record

Markets served

BPEA business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Fund Management Fees: BPEA generates revenue through management fees and carried interest from private equity funds including BPEA V ($218M) and BPEA Strategic Healthcare ($352M). The firm builds diversified and balanced private equity programs investing in fund managers and directly in companies.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

BPEA product offering

Product offering

Core offering

BPEA is a private equity firm that manages dedicated small and lower middle market buyout and growth equity investment programs for institutional investors. The firm builds diversified private equity portfolios by investing in fund managers and directly in US-based companies across business services & software, healthcare, consumer & retail, and industrial sectors, with a specialized healthcare-only program supported by Taft-Hartley investors.

Product overview

BPEA is a Boston-based private equity firm established in 2002 offering investment programs including Small Buyout and Growth (targeting companies with EBITDA below $10M and enterprise values below $100M), dedicated Healthcare funds (investing in healthcare services, healthcare IT, and consumer-oriented healthcare), and Customized separate accounts. The firm manages funds like BPEA V ($218M) and BPEA Strategic Healthcare ($352M). BPEA invests in both fund managers and directly in private companies across business services & software, healthcare, consumer & retail, and industrial sectors.

Differentiator

Problem solved

Functional benefit

Products and services

  • BPEA V Small buyout and growth equity fund investing in US-based companies with EBITDA below $10 million and enterprise values below $100 million across business services & software, healthcare, consumer & retail, and industrial sectors, both in funds and alongside funded and independent sponsors. Closed at $218M in December 2020.
  • BPEA Strategic Healthcare Fund Dedicated healthcare private equity fund investing in private healthcare companies directly and through specialist healthcare private equity firms. Targets companies addressing critical healthcare needs and improving access to cost-effective, high quality healthcare. Closed at $352M in 2020 from 16 Taft-Hartley Investors.
  • Small Buyout and Growth Program Investment program targeting profitable US businesses with enterprise values below $100 million and EBITDA between $1 million and $10 million, as well as sector-focused fund managers with fund sizes generally below $300 million. Builds diversified, balanced small-market PE portfolios.
  • Healthcare Investment Program Healthcare-focused investment program investing in fund managers and direct portfolio companies across healthcare services, healthcare IT, and consumer-oriented healthcare sectors. Leverages Taft-Hartley investor relationships for strategic value-add to portfolio companies serving those plans.
  • Customized Investment Solutions Customized private equity programs developed for institutional investors, including global mandates, regionally-concentrated programs, and MWBE-focused investment strategies tailored to specific long-term goals.

Quantifiable outcome

  • BPEA V closed at $218 million exceeding its $200 million target
  • +2 more outcomes

Companies that use BPEA

Customer profile

Named customers89 records

Segments4 records

Ideal customer profiles3 records

BPEA technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

BPEA partnerships and signals

Strategic signal

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

BPEA competitors and assessment

Company assessment

Direct peers

  • The Riverside Company: Globally focused lower middle market private equity firm investing in companies with EBITDA typically under $25M. Highly comparable to BPEA's sub-$100M EV, sub-$10M EBITDA small buyout strategy across multiple sectors.
  • Audax Group: Middle market private equity firm focused on buyouts of North American companies. Comparable to BPEA as a lower middle market PE sponsor pursuing control investments with similar institutional LP base.
  • Atlantic Street Capital: Lower middle market private equity firm investing in services, healthcare, and consumer companies. Directly comparable to BPEA in target company size and sector focus, including healthcare exposure.
  • Garnett Station Partners: Lower middle market PE firm focused on consumer, business services, and healthcare. Comparable to BPEA in fund size, target company profile, and multi-sector small buyout strategy.
  • Revelstoke Capital Partners: Healthcare-focused private equity firm investing in lower middle market healthcare services and technology companies. Directly comparable to BPEA Strategic Healthcare's dedicated healthcare mandate.
  • Linden Capital Partners: Healthcare-focused private equity firm investing in middle market healthcare companies. Comparable to BPEA's dedicated healthcare fund strategy and target company size range.
  • HGGC: Middle market private equity firm investing in North American companies across business services, healthcare, and consumer. Comparable to BPEA in lower middle market focus and sector breadth.

Broad incumbents

  • Advent International: Global private equity firm co-founded by Peter Brooke, BPEA's late co-founder. Comparable as a multi-fund, multi-sector PE platform with shared founding lineage, though operating at substantially larger scale.
  • TA Associates: Global growth private equity firm also founded by Peter Brooke. Comparable as a multi-fund PE platform sharing founder pedigree, though focused on growth equity at larger company sizes than BPEA's small buyout strategy.

Others

  • HarbourVest Partners: Private markets investment manager and fund-of-funds. Comparable to BPEA's fund-of-funds activity investing in other PE managers, though HarbourVest operates at significantly larger scale as a multi-strategy alternatives platform.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

BPEA social profiles

Digital presence

BPEA financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BPEA leadership team

Management profile

Number of profiles

Profiles19 records

BPEA funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BPEA M&A and investment

M&A and investment

M&A1 record

Investments23 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BPEA

What does BPEA do?

BPEA is a private equity firm that manages dedicated small and lower middle market buyout and growth equity investment programs for institutional investors. The firm builds diversified private equity portfolios by investing in fund managers and directly in US-based companies across business services & software, healthcare, consumer & retail, and industrial sectors, with a specialized healthcare-only program supported by Taft-Hartley investors.

Is BPEA a public or private company?

BPEA is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was BPEA founded?

BPEA was founded in 2002. It employs 11 to 50 people.

Where is BPEA based?

BPEA is headquartered in Boston, United States, in the North America region.

How does BPEA make money?

One revenue line is on record: fund Management Fees.

Who are BPEA's main competitors?

Direct peers on record are The Riverside Company, Audax Group, Atlantic Street Capital, Garnett Station Partners, Revelstoke Capital Partners, Linden Capital Partners and HGGC. Broad incumbents are Advent International and TA Associates. HarbourVest Partners is listed as an others.

Does BPEA have an API?

No public API is recorded for BPEA.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
DealStreetAsiaTwo speeds define SE Asia’s private capital funds marketNo dedicated Southeast Asia private equity fund closed in H1 2026, while only one VC vehicle did. Pan-Asian and global funds with minority regional allocations recorded the strongest semester, but capital remains concentrated among established managers. The report expects the next cycle to become more thematic and sovereign-influenced.PR NewswireMatt Plachta Joins BPEA as Vice President of Healthcare PartnershipsBPEA, a Boston-based private equity firm, announced the appointment of Matt Plachta as Vice President of Healthcare Partnerships to accelerate initiatives for the BPEA Strategic Healthcare funds focused on Taft-Hartley pension fund investors. Plachta brings over 18 years of healthcare benefits consulting and actuarial experience, along with recent sales experience at a private equity-backed healthcare services company. The firm indicated the hire is designed to deepen relationships with Taft-Hartley investors and help portfolio companies address the needs of Taft-Hartley health and welfare plans.GlobeNewswireAMG Reports Financial and Operating Results for the First Quarter of 2022AMG reported Q1 2022 EPS of $3.44 and economic EPS of $4.65, with net income of $146 million and adjusted EBITDA of $255 million. The company also announced a $1 billion cash and stock value from its BPEA-EQT combination and repurchased $185 million in shares.PR NewswireBPEA Closes Oversubscribed BPEA V at $218 MillionBPEA, a Boston-based private equity firm established in 2002, announced the final close of its BPEA V fund at $218 million in commitments, exceeding its $200 million target. The fund will invest in small buyout and growth equity opportunities in US-based companies across business services & software, healthcare, consumer & retail, and industrial sectors, targeting companies with EBITDA below $10 million and enterprise values below $100 million. The fund received support from existing and new investors including pension funds, foundations, endowments, and family offices, and follows the earlier 2020 close of BPEA Strategic Healthcare at $352 million.PR NewswireLincoln International represents Farol Asset Management, Fulham & Co., Brooke Private Equity Associates and Management Shareholders in the sale of Delphon Industries to PWP Growth EquityLincoln International served as exclusive financial advisor to the shareholders of Delphon Industries, including Farol Asset Management, Fulham & Co., Brooke Private Equity Associates and Management, in the sale of the company to PWP Growth Equity. Delphon is a provider of chemistry and engineering solutions for handling, processing, packaging and marking of high-value technology and medical components serving semiconductor, optoelectronics, data storage, medical, aerospace, defense and telecom markets, headquartered in Hayward, California with operations in Wilsonville, Oregon. Rob Azeke, Founder and Managing Partner of Farol Asset Management, stated that the process generated tremendous interest and achieved an excellent result for Delphon's shareholders.